Clinical studies are a critical step in developing new therapies that have the potential to improve the lives of patients facing serious diseases. At Liferna, we are committed to conducting clinical research responsibly, ethically, and with a focus on patient safety.
Our clinical development programs evaluate investigational therapies across autoimmune and fibrotic diseases, helping us better understand their safety and effectiveness while working toward new treatment options for patients with significant unmet medical needs.
Liferna does not currently have any active clinical studies enrolling participants. Please check back for updates, as information about future studies will be posted here as they become available.
